Search
Advocacy Menu
Advocacy Home
Activites and Events
Advocacy Newsletter Archives
ASAM Public Policy
Advocacy Toolkit
ASAM Video

Advocacy News Archive

Published monthly for the benefit of ASAM members, ASAM Advocacy News is an electronic newsletter that highlights ASAM's most recent legislative and regulatory advocacy news, in addition to ASAM federal legislative and regulatory updates, and State Legislative announcements.
 

ASAM Advocacy News - Spring 2009

ASAM Advocacy News - Winter 2009

ASAM Advocacy News - Fall 2008

ASAM Advocacy News - Spring 2008

ASAM Advocacy News - Summer 2008

ASAM Advocacy News - Winter 2008

ASAM Advocacy News - Summer 2007

 

 

National Alcohol & Drug Addiction Recovery Month 

 
 
Partnership to Fight Chronic Disease

Advocacy Action Items

 

How to Prepare for a DEA Office Inspection

ASAM members who have a Drug Enforcement Administration (DEA) registration to prescribe buprenorphine/naloxone or buprenorphine in an office setting may be inspected by the Drug Enforcement Agency (DEA).  [DEA Inspection Guidance]

 
Physician Locator For Patients and Families Developed
If you are looking for doctors in your area who can prescribe buprenorphine for opioid addiction click here for the SAMHSA [Buprenorphine Physician Locator]
New PCSS Web Site

This is a new website designed primarily for mentors, which features the web-based system they use for contacts and a restricted list serve [www.PCSSmentor.org]

 

ASAM Membership
Join Now
Renew ASAM’s Membership
Copyright 2005 American society of Addiction Medicine. ASAM and American Society of Addiction Medicine are registered trademarks of the American Society of Addiction Medicine ("ASAM"). All Trademarks, service marks and logos displayed on this website are registered and unregistered trademarks and/or service marks of ASAM or other trademark owners and may not be copied, reproduced, used, or displayed.